Related Experiment Video

Updated: Aug 17, 2026

In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically

D Santini, B Vincenzi, G Perrone

    Annals of Oncology : Official Journal of the European Society for Medical Oncology
    |June 24, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
    09:04

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

    Published on: March 15, 2016

    Related Experiment Videos

    Last Updated: Aug 17, 2026

    In Vitro Model of Coronary Angiogenesis
    08:03

    In Vitro Model of Coronary Angiogenesis

    Published on: March 10, 2020

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
    09:04

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

    Published on: March 15, 2016

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

    Articles linked to this work by shared authors, journal, and citation graph.

    Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis.

    Breast cancer research and treatment·2026

    Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network.

    ESMO open·2026

    Medical decision analysis for personalized oncology at the patient bedside.

    Tumori·2026

    Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025

    Pazopanib in the real-world setting in soft tissue sarcomas: data from the Italian national registry.

    ESMO open·2024

    Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study.

    ESMO open·2024

    Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase Ib study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma.

    Frontiers in oncology·2026

    Nanoprobe-Enabled Precision Imaging and Panoramic Boundary Delineation in Retinoblastoma.

    Cancer innovation·2026

    Number of examined lymph nodes and overall survival in intrahepatic cholangiocarcinoma: a population-based study suggesting a staging benefit.

    Frontiers in oncology·2026

    LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase.

    Frontiers in pharmacology·2026

    Lactate metabolism and lactylation in uveal melanoma: from metabolic adaptation to immune regulation.

    Frontiers in immunology·2026

    Associations between C-reactive protein-triglyceride glucose index and asthma risk among Chinese adults: evidence from the CHARLS cohort and external hospital-based validation.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us